Drug Profile
Research programme: antibacterials - Teva
Alternative Names: TV-7130Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Teva Pharmaceutical Industries
- Class Amino acids; Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Septic shock
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Septic-shock in Israel (IV, Infusion)
- 16 Nov 2006 Preclinical trials in Septic shock in Israel (IV)